X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    FDA Accepts BLA for Recommended

    FDA Accepts BLA for Recommended Biosimilar to Simponi

    Merck to Acquire Verona

    Merck to Acquire Verona Pharma in $10B Deal Boosts COPD Drug

    Emerging Oral Small Molecule Drugs

    Emerging Oral Small-Molecule Drugs for Ultra-Rare Diseases

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    FDA Accepts BLA for Recommended

    FDA Accepts BLA for Recommended Biosimilar to Simponi

    Merck to Acquire Verona

    Merck to Acquire Verona Pharma in $10B Deal Boosts COPD Drug

    Emerging Oral Small Molecule Drugs

    Emerging Oral Small-Molecule Drugs for Ultra-Rare Diseases

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Asia

Sanofi, Novonordisk and Novartis Iran are 2018’s Best Places to Work in Iran

Content Team by Content Team
22nd March 2018
in Asia, News
Sanofi, Novonordisk and Novartis Iran are 2018’s Best Places to Work in Iran

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Best Places to Work program is an international program providing employers in different regions the opportunity to learn more about the engagement and satisfaction of their employees and honor those who deliver an outstanding work experience. Additionally, The Best Places To Work certification is awarded to companies with the highest standards of excellence in regards to working conditions.

The first position was awarded to Sanofi Iran, a multinational pharmaceutical company focusing on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions. Within the company, employees are the most valuable resource and the company supports and encourages their success by promoting a healthy work-life balance. “BPTW provided a good opportunity to benchmark our employee engagement level and HR processes with the rest of the market,” saidKhosro Aghajanian, HR Director for Sanofi Iran.

Novonordisk Iran, a world leader healthcare company, came as the second best place to work, thanks to a clear vision and an unparalleled work environment providing learning opportunities, development and evolution for the employees. “Our office is filled with energy, passion and momentum around bringing change for people living with chronic conditions in Iran,” said Ghobad Shahbazi, General Manager & Corporate Vice President for Novonordisk Iran.

Novartis Iran, a global healthcare company committed to improving health and well-being through innovative products and services, came as the third best place to work for in Iran for 2018. The company provides a great working environment for its employees including career opportunities encouraging associates to stay longer. ”Novartis Iran is the best Place to work, since it highly values its associates, and patients are at the core of everything we do,” said Alireza Afsarian, HR Director for Novartis Iran.

“This certification validates the commitment of companies in Iran to provide the employees with a positive work environment that challenges and encourages them to develop personally and professionally,” said Hamza Idrissi Program Manager for Iran.

The experience of working with organizations across different sectors in the Iran tells us that leaders at the best workplaces place employees at the heart of their business strategy and consider building a great workplace among their top business goals.

Previous Post

Chemspec Europe 2018:Introduction of Partnering Programme adds new level of networking

Next Post

Biogen plans to present its advances in Alzheimer’s and Parkinson’s Therapies, an AAT-AD/PD Focus Meeting

Related Posts

FDA Accepts BLA for Recommended
FDA Approvals

FDA Accepts BLA for Recommended Biosimilar to Simponi

22nd July 2025
Merck to Acquire Verona
Drug Development

Merck to Acquire Verona Pharma in $10B Deal Boosts COPD Drug

21st July 2025
ChiRhoClin LogiCare3PL Partners for Drug Distribution
News

ChiRhoClin, LogiCare3PL Partners for Drug Distribution

21st July 2025
Thermo Fisher and Sanofi Partners
Manufacturing

Thermo Fisher and Sanofi Partners for US Drug Manufacturing

21st July 2025
EMA Recommendations to Secure Anti D Immunoglobulins Supply
News

EMA Recommendations to Secure Anti-D Immunoglobulins Supply

15th July 2025
FDA Approves Oral Therapy for Treating Hereditary Angioedema
FDA Approvals

FDA Approves Oral Therapy for Treating Hereditary Angioedema

15th July 2025
Next Post

Biogen plans to present its advances in Alzheimer’s and Parkinson’s Therapies, an AAT-AD/PD Focus Meeting

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In